Man­u­fac­tur­ing sites in Ger­many and Chi­na hit with warn­ing let­ters over QC and clean­ing is­sues

Two sep­a­rate drug man­u­fac­tur­ers have been cit­ed by US reg­u­la­tors over sev­er­al in­frac­tions in­clud­ing qual­i­ty, clean­ing and oth­er is­sues.

The FDA on Tues­day re­leased two …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER